| Trial Identifier: | D133HR00023 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Hospital Israelita Albert Einstein
|
| NCTID:: | NCT05945108 |
| Start Date: | July 2023 |
| Primary Completion Date: | July 2024 |
| Study Completion Date: | July 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Brazil, Minas Gerais | Belo Horizonte, Minas Gerais, Brazil, 30380-472 |
| Brazil, Pernambuco | Recife, Pernambuco, Brazil, 50070-902 |
| Brazil, Rio Grande do Sul | Porto Alegre, Rio Grande do Sul, Brazil, 90020-090 |
| Brazil, Rio Grande do Sul | Porto Alegre, Rio Grande do Sul, Brazil, 90035-001 |
| Brazil, Salvador | Rio Vermelho, Salvador, Brazil, 41950-640 |
| Brazil, Santa Catarina | Florianópolis, Santa Catarina, Brazil, 88034-000 |
| Brazil, São Paulo | São José do Rio Preto, São Paulo, Brazil, 15090-000 |
| Brazil, São Paulo | São Paulo, Brazil, 05652-900 |
| Brazil, São Paulo | São Paulo, Brazil, 04029-001 |
| Brazil, São Paulo | São Paulo, Brazil, 04378-500 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company